← Back to Search

Preferences for Open Vs. Endovascular Repair for Abdominal Aortic Aneurysm (PROVE-AAA Trial)

N/A
Waitlist Available
Led By Philip Goodney, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Veteran with a \> or = 5.0 cm AAA who are candidates for both open and endovascular surgical repair, with no previous AAA repair surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether or not a decision aid helps Veterans make a decision about surgery for their Abdominal Aortic Aneurysm.

Eligible Conditions
  • Abdominal Aortic Aneurysm

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Agreement Between Veterans Preferences for Repair Type and Actual Repair Type
Veteran Preference for Repair Type
Secondary study objectives
Decision Regret Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: decision aidExperimental Treatment1 Intervention
the experimental group will receive the decision aid
Group II: controlActive Control1 Intervention
the control group will only receive the survey

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,668 Previous Clinical Trials
3,765,625 Total Patients Enrolled
Philip Goodney, MDPrincipal InvestigatorWhite River Junction VA Medical Center, White River Junction, VT
1 Previous Clinical Trials
20,000 Total Patients Enrolled
~28 spots leftby Jan 2026